clavulanic acid has been researched along with cephalexin in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (52.63) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 2 (10.53) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Hall, TW; Ishida, N; Maiti, SN; Micetich, RG; Nakai, A; Ogawa, K; Spevak, P; Tanaka, M; Yamabe, S; Yamazaki, T | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Aubé, J; Ballinger, E; Dartois, V; Gold, B; Hanson, P; Ling, Y; Little, D; Lopez Quezada, L; Mitscher, LA; Nathan, C; Nguyen, Q; Pingle, M; Porubsky, P; Roberts, J; Rogers, S; Schoenen, FJ; Smith, R; Somersan, S; Warrier, T; Zhang, D; Zimmerman, M | 1 |
| Braschi, R; Moreo, G; Nani, M; Remotti, G; Sardi, C | 1 |
| Beskid, G; Durkin, JW; Fallat, V; Lipschitz, ER; McGarry, DH; Siebelist, J | 1 |
| Lauderdale, BL; Washington, JA; Yu, PK | 1 |
| Ayers, LW; Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN; Thornsberry, C | 1 |
| Iravani, A; Richard, GA | 1 |
| Carlin, SA; Feinstein, JC; Flexon, P; Fulton, D; Johnson, CE; Marchant, CD; Murdell-Panek, D; Shurin, PA; Van Hare, GF | 1 |
| Bint, AJ; Pedler, SJ | 1 |
| Gurwith, D; Gurwith, MJ; Stein, GE | 1 |
| Pien, FD | 1 |
| de Sá Del Fiol, F; Groppo, FC; Rocha De Mattos Filho, T | 1 |
| Chung, JH; Clock, CA; Ehsanipoor, RM; McNulty, JA; Wing, DA | 1 |
| Minami, K; Nishihara, M; Oda, K; Suzuki, K; Uchiyama, K; Ukimura, A; Yamada, T | 1 |
| Bio, LL; Yu, D | 1 |
1 review(s) available for clavulanic acid and cephalexin
| Article | Year |
|---|---|
Shedding Light on Amoxicillin, Amoxicillin-clavulanate, and Cephalexin Dosing in Children from a Pharmacist's Perspective.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalexin; Child; Clavulanic Acid; Humans; Microbial Sensitivity Tests; Pharmacists | 2022 |
6 trial(s) available for clavulanic acid and cephalexin
| Article | Year |
|---|---|
[Comparison of an antibiotic combination (amoxicillin + clavulanic acid) and cefaclor in the treatment of acute or flare-ups of chronic bronchopneumopathies].
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Asthma; Bronchitis; Cefaclor; Cephalexin; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged | 1988 |
Amoxicillin-clavulanic acid versus cefaclor in the treatment of urinary tract infections and their effects on the urogenital and rectal flora.
Topics: Adolescent; Adult; Amoxicillin; Cefaclor; Cephalexin; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Humans; Penicillin Resistance; Random Allocation; Rectum; Urinary Tract Infections; Urogenital System | 1986 |
A randomized controlled trial of amoxicillin plus clavulanate compared with cefaclor for treatment of acute otitis media.
Topics: Acute Disease; Amoxicillin; Cefaclor; Cephalexin; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Haemophilus influenzae; Humans; Infant; Male; Neisseria; Otitis Media; Otitis Media with Effusion; Random Allocation; Streptococcus pneumoniae | 1986 |
Comparative study of amoxicillin-clavulanic acid and cephalexin in the treatment of bacteriuria during pregnancy.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteriuria; Cephalexin; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Female; Humans; Pregnancy; Pregnancy Complications, Infectious | 1985 |
Prospective comparison of amoxicillin-clavulanic acid and cefaclor in treatment of uncomplicated urinary tract infections.
Topics: Adult; Amoxicillin; Ampicillin; Cefaclor; Cephalexin; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Female; Humans; Male; Penicillin Resistance; Prospective Studies; Urinary Tract Infections | 1983 |
Double-blind comparative study of two dosage regimens of cefaclor and amoxicillin-clavulanic acid in the outpatient treatment of soft tissue infections.
Topics: Adult; Amoxicillin; Bacterial Infections; Cefaclor; Cephalexin; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Humans | 1983 |
12 other study(ies) available for clavulanic acid and cephalexin
| Article | Year |
|---|---|
Synthesis and beta-lactamase inhibitory properties of 2 beta-[(1,2,3-triazol-1-yl)methyl]-2 alpha-methylpenam-3 alpha-carboxylic acid 1,1-dioxide and related triazolyl derivatives.
Topics: Ampicillin; Bacteria; beta-Lactamase Inhibitors; Chemical Phenomena; Chemistry; Clavulanic Acid; Clavulanic Acids; Escherichia coli; Penicillanic Acid; Sulbactam; Tazobactam; Triazoles | 1987 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Cells, Cultured; Cephalosporins; Female; Hep G2 Cells; Humans; Macrophages; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Microsomes, Liver; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis | 2016 |
In vitro activity of Ro 19-5247 (T-2525) and interpretive criteria for disk diffusion susceptibility testing.
Topics: Acinetobacter; Amoxicillin; Bacteria; Cefaclor; Cefmenoxime; Cefuroxime; Cephalexin; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus; Streptococcus | 1987 |
In vitro activity of an orally administered cephalosporin, LY164846, against potentially pathogenic respiratory and dermal bacterial isolates.
Topics: Amoxicillin; Cephalexin; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Dose-Response Relationship, Drug; Drug Combinations; Haemophilus influenzae; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Respiratory System; Skin; Staphylococcus aureus; Time Factors | 1986 |
In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteria.
Topics: Amoxicillin; beta-Lactamases; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Cephalexin; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Escherichia coli; In Vitro Techniques; Pseudomonas; Staphylococcus | 1986 |
Evaluation in an animal model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains.
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Ceftriaxone; Cephalexin; Cephalosporin Resistance; Cephalosporins; Clavulanic Acid; Disease Models, Animal; Drug Therapy, Combination; Male; Microbial Sensitivity Tests; Rats; Rats, Wistar; Staphylococcus aureus | 2000 |
A retrospective review of ampicillin-sulbactam and amoxicillin + clavulanate vs cefazolin/cephalexin and erythromycin in the setting of preterm premature rupture of membranes: maternal and neonatal outcomes.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Cephalexin; Chorioamnionitis; Clavulanic Acid; Drug Therapy, Combination; Endometritis; Enterocolitis, Necrotizing; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Pregnancy; Pregnancy Outcome; Retrospective Studies; Sulbactam | 2008 |
Probability of target attainment of oral antimicrobials for Escherichia coli and Klebsiella pneumoniae based on Monte Carlo simulations.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cephalexin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Monte Carlo Method; Probability | 2022 |